{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:50:51Z","timestamp":1770072651607,"version":"3.49.0"},"reference-count":49,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Postdoctoral Science Foundation","award":["2020M680267"],"award-info":[{"award-number":["2020M680267"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Vaccination is considered the most effective and economical measure for controlling infectious diseases. Although combination vaccines are widely used worldwide, whether any of the combination vaccines is superior to each separate vaccine has yet to be established. This systematic review and meta-analysis aimed to summarize the available evidence on the effectiveness and safety of combination vaccines in children. Methods: A systematic search was conducted from database inception to August 20, 2021, in MEDLINE, Embase, Cochrane, and Scopus. Published randomized clinical trials (RCTs) and open-label trials of immunogenicity and safety of combined vaccines were selected. The results of the studies were quantitatively synthesized. Results: Overall, 25 articles met the inclusion criteria and were included in the meta-analysis. The results indicated that the combined diptheria\u2013tetanus\u2013acellular pertussis (DTaP)\u2013hepatitis B virus (HBV)\u2013Haemophilus influenzae type B (Hib) vaccine group had lower levels of anti-tetanus antibodies than the combined DTaP\u2013HBV and separate Hib vaccinations group (SMD = \u22120.23; 95% CI: \u22120.42, \u22120.05; p = 0.013). Meanwhile, the combined DTaP\u2013HBV\u2013inactivated polio virus (IPV)\u2013Hib vaccine group had higher levels of anti-pertussis (PT) and anti-filamentous hemagglutinin (FHA) antibodies than the combined DTaP\u2013IPV\u2013Hib and separate HBV vaccinations group (anti-PT: SMD = 0.60; 95% CI: 0.45, 0.75; p &lt; 0.0001; anti-FHA: SMD = 0.40; 95% CI: 0.01, 0.78; p = 0.042). The levels of anti-pertactin (PRN) antibodies were lower in the combined DTaP\u2013IPV\u2013Hib vaccine group than in the combined DTaP\u2013IPV and separate Hib vaccinations group (SMD = \u22120.13; 95% CI: \u22120.27, \u22120.00; p = 0.047). The individuals injected with the DTaP\u2013HBV\u2013IPV\u2013Hib vaccine had a lower risk of pain and swelling than those injected with the combined DTaP\u2013HBV\u2013IPV and separate Hib vaccines (pain: RR = 0.79; 95% CI: 0.69, 0.91; p = 0.001; swelling: RR = 0.87; 95% CI: 0.78, 0.98; p = 0.020). However, the group that received the DTaP\u2013HBV\u2013IPV\u2013Hib vaccine had a higher risk of fever than the group that received DTaP\u2013HBV\u2013IPV and separate Hib vaccinations (RR = 1.13; 95% CI: 1.02, 1.26; p = 0.021). Conclusions: This meta-analysis suggests that the combined vaccines (DTaP\u2013IPV\u2013Hib, DTaP\u2013HBV\u2013Hib, DTaP\u2013HBV\u2013IPV\u2013Hib) are safe, well-tolerated, and provide immunogenic alternatives to separate vaccines in children. The combined DTaP\u2013HBV\u2013IPV\u2013Hib vaccine showed a higher incidence of fever, which was lower than the cumulative incidence of fever induced by all vaccines. Future studies should evaluate the cost-effectiveness of using combined vaccines and compare the potency of different formulations to improve routine local or national childhood immunization programs.<\/jats:p>","DOI":"10.3390\/vaccines10030472","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:37:17Z","timestamp":1647812237000},"page":"472","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Immunogenicity and Safety of Childhood Combination Vaccines: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"10","author":[{"given":"Bei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing 400715, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingfeng","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-2946","authenticated-orcid":false,"given":"Tao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, School of Public Health, Hangzhou Normal University, Hangzhou 311121, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudong","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, College of Public Health, Zhengzhou University, Zhengzhou 450001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-0827","authenticated-orcid":false,"given":"Qingbin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing 100191, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s13346-021-00913-w","article-title":"An overview of chitosan and its application in infectious diseases","volume":"11","author":"Meng","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0140-6736(18)31612-X","article-title":"The Lancet Commission on global mental health and sustainable development","volume":"392","author":"Patel","year":"2018","journal-title":"Lancet"},{"key":"ref_4","unstructured":"World Health Organization (2022, February 05). Vaccine Introduction Guidelines. Available online: http:\/\/www.who.int\/immunization\/hpv\/plan\/vaccine:introduction_guidelines_who_2018.pdf.2018."},{"key":"ref_5","unstructured":"World Health Organization (2022, February 05). Global Immunization Vision and Strategy, 2006\u20132015. Available online: http:\/\/whqlibdoc.who.int\/hq\/2005\/WHO_IVB_05.05.pdf.2005."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0264-410X(96)00021-7","article-title":"Immunization against diphtheria with special emphasis on immunization of adults","volume":"14","author":"Galazka","year":"1996","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1093\/infdis\/jiaa684","article-title":"Diphtheria-Tetanus-Pertussis (DTP) Vaccine Is Associated With Increased female-Male Mortality. Studies of DTP administered before and after measles vaccine","volume":"223","author":"Hanifi","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/14760584.2020.1843434","article-title":"Efficacy, safety, and formulation issues of the combined vaccines","volume":"19","author":"Tafreshi","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s13312-019-1651-y","article-title":"Hexavalent Vaccines in India: Current Status","volume":"56","author":"Chitkara","year":"2019","journal-title":"Indian Pediatr."},{"key":"ref_10","unstructured":"Centers for Disease Control and Prevention (2022, February 05). Combination Vaccines, Available online: https:\/\/www.cdc.gov\/vaccines\/parents\/why-vaccinate\/combination-vaccines.html."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The value of childhood combination vaccines: From beliefs to evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1345\/aph.1M468","article-title":"New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV\/Hib (Pentacel)","volume":"44","author":"Johns","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1016\/j.vaccine.2017.09.046","article-title":"A systematic review of factors affecting vaccine uptake in young children","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/j.vaccine.2017.07.061","article-title":"The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations","volume":"35","author":"Karafillakis","year":"2017","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/hv.26269","article-title":"Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix\u2122 hexa: Twelve years of experience in Italy","volume":"10","author":"Baldo","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","article-title":"Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan","volume":"26","author":"Nakayama","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.vaccine.2014.06.070","article-title":"Lasting immune memory against hepatitis B following challenge 10\u201311 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV\/Hib or monovalent hepatitis B vaccine at 3, 5 and 11\u201312 months of age","volume":"33","author":"Avdicova","year":"2015","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3346\/jkms.2016.31.9.1383","article-title":"The Immunogenicity and Safety of a Combined DTaP-IPV\/\/Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: A Randomized Clinical Trial in South Korean Infants","volume":"31","author":"Kang","year":"2016","journal-title":"J. Korean Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bar-On, E.S., Goldberg, E., Fraser, A., Vidal, L., Hellmann, S., and Leibovici, L. (2009). Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst. Rev., Cd005530.","DOI":"10.1002\/14651858.CD005530.pub2"},{"key":"ref_20","unstructured":"World Health Organization (2019). Vaccine-Preventable Diseases and Vaccines, WHO."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(95)90471-9","article-title":"A new method for active surveillance of adverse events from diphtheria\/tetanus\/pertussis and measles\/mumps\/rubella vaccines","volume":"345","author":"Farrington","year":"1995","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jama.2012.165","article-title":"Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b","volume":"307","author":"Sun","year":"2012","journal-title":"Jama-J. Am. Med. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Traversa, G., Spila-Alegiani, S., Bianchi, C., Ciofi degli Atti, M., Frova, L., Massari, M., Raschetti, R., Salmaso, S., and Scalia Tomba, G. (2011). Sudden unexpected deaths and vaccinations during the first two years of life in Italy: A case series study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016363"},{"key":"ref_24","first-page":"43","article-title":"Infanrix hexa and sudden death: A review of the periodic safety update reports submitted to the European Medicines Agency","volume":"3","author":"Puliyel","year":"2018","journal-title":"Indian J. Med. Ethics"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D., and PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"61mr1","DOI":"10.1126\/scitranslmed.3001738","article-title":"A crisis of public confidence in vaccines","volume":"2","author":"Black","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1086\/322575","article-title":"Combination vaccines: Choices or chaos? A practitioner\u2019s perspective","volume":"33","author":"Le","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5486869","DOI":"10.1155\/2016\/5486869","article-title":"Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes \u201ca\u201d and \u201cb\u201d","volume":"2016","author":"Konini","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/514741","article-title":"Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses","volume":"28","author":"Halperin","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/21645515.2016.1239670","article-title":"Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV\/Hib) administered in Chinese infants","volume":"13","author":"Li","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.47102\/annals-acadmedsg.V37N7p546","article-title":"Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus influenzae type b vaccine in a placebo-controlled rotavirus vaccine study","volume":"37","author":"Phua","year":"2008","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.vaccine.2015.02.015","article-title":"Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV\/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants","volume":"33","author":"Scheifele","year":"2015","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.vaccine.2012.02.024","article-title":"Immunogenicity of Infanrix\u2122 hexa administered at 3, 5 and 11 months of age","volume":"30","author":"Kuriyakose","year":"2012","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/00365540410017572","article-title":"Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age","volume":"36","author":"Gabutti","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","article-title":"Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1749-6632.1995.tb44436.x","article-title":"Potential alterations in immunogenicity by combining or simultaneously administering vaccine components","volume":"754","author":"Insel","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: A review on adjuvants in licensed vaccines","volume":"39","author":"Rappuoli","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s004310050544","article-title":"Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine","volume":"156","author":"Zepp","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"ref_39","unstructured":"World Health Organisation (2015). Pertussis vaccines: WHO position paper\u2013September 2015. Wkly. Epidemiol. Rec., 90, 433\u2013458."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhang, L., Prietsch, S.O., Axelsson, I., and Halperin, S.A. (2014). Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst. Rev., Cd001478.","DOI":"10.1002\/14651858.CD001478.pub6"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/21645515.2018.1549449","article-title":"Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: A randomized trial in the United States","volume":"15","author":"Klein","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4161\/hv.28480","article-title":"Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV\/Hib (Infanrix\u2122 hexa) vaccine","volume":"10","author":"Bleckmann","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.vaccine.2003.11.044","article-title":"Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants","volume":"22","author":"Zepp","year":"2004","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.1086\/322577","article-title":"Evaluating the safety of combination vaccines","volume":"33","author":"Ellenberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1542\/peds.2014-1729","article-title":"Duration of pertussis immunity after DTaP immunization: A meta-analysis","volume":"135","author":"McGirr","year":"2015","journal-title":"Pediatrics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1016\/j.vaccine.2008.07.021","article-title":"Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil","volume":"26","author":"Valentim","year":"2008","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Aljunid, S.M., Al Bashir, L., Ismail, A.B., Aizuddin, A.N., Rashid, S., and Nur, A.M. (2022). Economic impact of switching from partially combined vaccine \u201cPentaxim\u00ae and hepatitis B\u201d to fully combined vaccine \u201cHexaxim\u00ae\u201d in the Malaysian National Immunization Program. BMC Health Serv. Res., 22.","DOI":"10.1186\/s12913-021-07428-7"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.46234\/ccdcw2020.003","article-title":"Co-Administration of Multiple Childhood Vaccines\u2013Guangdong Province, 2019","volume":"2","author":"Li","year":"2020","journal-title":"China CDC Wkly."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/472\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:39:20Z","timestamp":1760135960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vaccines10030472"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10030472","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}